Efficient adaptation of high-quality international guidelines for Chinese children with primary immune thrombocytopenia.
作者信息
Liu Yali, Wu Runhui
机构信息
Center for Clinical Epidemiology and Evidence-based Medicine Beijing Children's Hospital Capital Medical University National Center for Children's Health Beijing China.
Hematology Center Beijing Children's Hospital Capital Medical University National Center for Children's Health Beijing China.
出版信息
Pediatr Investig. 2022 Mar 21;6(2):149-150. doi: 10.1002/ped4.12313. eCollection 2022 Jun.
Abstract
摘要
相似文献
1
Efficient adaptation of high-quality international guidelines for Chinese children with primary immune thrombocytopenia.为中国原发性免疫性血小板减少症患儿高效适配高质量国际指南。
Pediatr Investig. 2022 Mar 21;6(2):149-150. doi: 10.1002/ped4.12313. eCollection 2022 Jun.
2
Egyptian Pediatric Guidelines for the Management of Children with Isolated Thrombocytopenia Using the Adapted ADAPTE Methodology-A Limited-Resource Country Perspective.埃及儿童孤立性血小板减少症管理指南：采用适应性ADAPTE方法——从资源有限国家的视角出发
Children (Basel). 2024 Apr 9;11(4):452. doi: 10.3390/children11040452.
3
Chinese guidelines for treatment of adult primary immune thrombocytopenia.成人原发性免疫性血小板减少症中国治疗指南。
Int J Hematol. 2018 Jun;107(6):615-623. doi: 10.1007/s12185-018-2445-z. Epub 2018 Apr 4.
4
[Interpretation of the Guidance for Immune Thrombocytopenia-Review].
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018 Apr;26(2):621-625. doi: 10.7534/j.issn.1009-2137.2018.02.053.
5
Health-related quality of life in children with newly diagnosed immune thrombocytopenia.新诊断免疫性血小板减少症患儿的健康相关生活质量
Haematologica. 2014 Sep;99(9):1525-31. doi: 10.3324/haematol.2014.106963. Epub 2014 Jun 20.
6
Efficiency and safety of eltrombopag for multi-line failed Chinese patients with immune thrombocytopenia: cases with decreased megakaryocyte response well from single-center experience.艾曲泊帕对多线治疗失败的中国免疫性血小板减少症患者的有效性和安全性：单中心经验中巨核细胞反应降低的病例
Immunol Res. 2022 Feb;70(1):67-74. doi: 10.1007/s12026-021-09245-w. Epub 2021 Oct 20.
7
Intracranial haemorrhage among Chinese children with immune thrombocytopenia in a Hong Kong regional hospital.中国香港地区医院内患有免疫性血小板减少症的儿童的颅内出血。
Hong Kong Med J. 2013 Apr;19(2):129-34.
8
[Protocol for the study and treatment of primary immune thrombocytopenia: PTI-2018].[原发性免疫性血小板减少症的研究与治疗方案：PTI-2018]
An Pediatr (Engl Ed). 2019 Aug;91(2):127.e1-127.e10. doi: 10.1016/j.anpedi.2019.04.014. Epub 2019 Jun 6.
9
Thrombopoietin receptor agonists for prevention and treatment of chemotherapy-induced thrombocytopenia in patients with solid tumours.血小板生成素受体激动剂用于预防和治疗实体瘤患者化疗引起的血小板减少症。
Cochrane Database Syst Rev. 2017 Nov 27;11(11):CD012035. doi: 10.1002/14651858.CD012035.pub2.
10
The treatment of integrated traditional Chinese and Western medicine to cure severe immune thrombocytopenia in a patient in a minimally conscious state: a case report.
Ann Palliat Med. 2021 Mar;10(3):3483-3490. doi: 10.21037/apm-21-307.
本文引用的文献
1
Adapted guideline for the diagnosis and treatment of primary immune thrombocytopenia for Chinese children (2021).《中国儿童原发性免疫性血小板减少症诊疗指南（2021年版）》
Pediatr Investig. 2022 Feb 21;6(2):63-74. doi: 10.1002/ped4.12305. eCollection 2022 Jun.
2
American Society of Hematology 2019 guidelines for immune thrombocytopenia.美国血液学会 2019 年免疫性血小板减少症治疗指南。
Blood Adv. 2019 Dec 10;3(23):3829-3866. doi: 10.1182/bloodadvances.2019000966.
3
Updated international consensus report on the investigation and management of primary immune thrombocytopenia.更新的原发性免疫性血小板减少症的调查和管理国际共识报告。
Blood Adv. 2019 Nov 26;3(22):3780-3817. doi: 10.1182/bloodadvances.2019000812.
4
GRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT.用于采用、改编和全新制定可靠建议的GRADE证据到决策（EtD）框架：GRADE-ADOLOPMENT。
J Clin Epidemiol. 2017 Jan;81:101-110. doi: 10.1016/j.jclinepi.2016.09.009. Epub 2016 Oct 3.
5
Guideline adaptation: an approach to enhance efficiency in guideline development and improve utilisation.指南改编：提高指南制定效率和利用度的方法。
BMJ Qual Saf. 2011 Mar;20(3):228-36. doi: 10.1136/bmjqs.2010.043257. Epub 2011 Jan 5.
Zotero 插件